Evidence map›Paper›PMID 29311744›Full record

ArticleNature neuroscience2018

Mutations in Vps15 perturb neuronal migration in mice and are associated with neurodevelopmental disease in humans.

Thomas Gstrein, Andrew Edwards, Anna Přistoupilová, Ines Leca, Martin Breuss, Sandra Pilat-Carotta, Andi H Hansen, Ratna Tripathy, Anna K Traunbauer, Tobias Hochstoeger and 17 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Synaptic Proteostasis in Health and Disease.Journal of neurochemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Understanding the Molecular Basis of Miller-Dieker Syndrome.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Autophagy and Its Lineage-Specific Roles in the Hematopoietic System.Oxidative medicine and cellular longevity · 2023
    Review
  13. Review
  14. Macroautophagy in CNS health and disease.Nature reviews. Neuroscience · 2022
    Review
  15. Review
  16. Autophagy in major human diseases.The EMBO journal · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 5 countries.

Thomas GstreinInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Andrew EdwardsWellcome Trust Center for Human Genetics (WTCHG), Oxford, UK.
Anna PřistoupilováInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.ORCID 0000-0003-0047-9405
Ines LecaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Martin BreussInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Sandra Pilat-CarottaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Andi H HansenInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Ratna TripathyInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Anna K TraunbauerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Tobias HochstoegerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Gavril RosoklijaInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Marco RepicInstitute for Molecular Biotechnology (IMBA), Vienna, Austria.
Lukas LandlerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Viktor StráneckýInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.
Gerhard DürnbergerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Thomas M KeaneWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
Johannes ZuberInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
David J AdamsWellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.
Jonathan FlintWellcome Trust Center for Human Genetics (WTCHG), Oxford, UK.
Tomas HonzikDepartment of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Marta GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Sergi BeltranCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Karl MechtlerInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria.
Elliott SherrInstitute of Human Genetics, University of California, San Francisco, San Francisco, CA, USA.
Stanislav KmochInstitute of Inherited Metabolic Disorders, Charles University, Prague, Czech Republic.
Ivo GutCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
David A KeaysInstitute of Molecular Pathology (IMP), Vienna Biocentre (VBC), Vienna, Austria. keays@imp.ac.at.ORCID 0000-0002-8343-8002
Research Institute of Molecular Pathology · ATUniversitat Pompeu Fabra · ESCharles University · CZCentre for Human Genetics · GBWellcome Sanger Institute · GBInstitute of Molecular Biotechnology · ATUniversity of California, San Francisco · US

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
Austrian Science Fund FWF I 914NINDS NIH HHS R01 NS058721
6 · The paper itself

Abstract

The formation of the vertebrate brain requires the generation, migration, differentiation and survival of neurons. Genetic mutations that perturb these critical cellular events can result in malformations of the telencephalon, providing a molecular window into brain development. Here we report the identification of an N-ethyl-N-nitrosourea-induced mouse mutant characterized by a fractured hippocampal pyramidal cell layer, attributable to defects in neuronal migration. We show that this is caused by a hypomorphic mutation in Vps15 that perturbs endosomal-lysosomal trafficking and autophagy, resulting in an upregulation of Nischarin, which inhibits Pak1 signaling. The complete ablation of Vps15 results in the accumulation of autophagic substrates, the induction of apoptosis and severe cortical atrophy. Finally, we report that mutations in VPS15 are associated with cortical atrophy and epilepsy in humans. These data highlight the importance of the Vps15-Vps34 complex and the Nischarin-Pak1 signaling hub in the development of the telencephalon.

Indexed as

Neurodevelopmental DisordersAlkylating AgentsAnimalsAnimals, NewbornAtrophyAutophagyBrainCell MovementDisease Models, AnimalEmbryo, MammalianEthylnitrosoureaFemaleGene Expression Regulation, DevelopmentalHumansMaleMiceAlkylating AgentsEthylnitrosoureaVacuolar Proton-Translocating ATPasesVps50 protein, mouse

Identifiers

PMID29311744
PMCPMC5897053
OpenAlexW2782387362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.